Notably, we showed that high LINC00152 expression is significantly correlated with high PDE4D/low ferroptosis and worse survival in multiple cohorts of tamoxifen- or tamoxifen-containing endocrine therapy-treated ER+ breast cancer patients, thereby demonstrating the clinical relevance of the axis we identified. This evidence concerns the gene PDE4D and breast carcinoma.